Target intelligence / Profile preview

Rhox homeobox family member 1 pseudogene 2 (RHOXF1P2)

Target
RHOXF1P2
Molecular classification
Pseudogene, Processed pseudogene, Noncoding RNA
01

Overview

**Rhox homeobox family member 1 pseudogene 2** (RHOXF1P2) is a processed pseudogene, meaning it is a noncoding sequence in the genome that arose from the Rhox homeobox family member 1 gene through retrotransposition events and has lost its protein-coding ability. RHOXF1P2 does not code for a functional protein, and there is no evidence it serves as a direct therapeutic target, receptor, enzyme, or transporter[5][1][3]. Pseudogenes like RHOXF1P2 may, however, play roles in gene regulation at the RNA level, such as acting as decoys for microRNAs or generating regulatory RNAs, thereby potentially influencing the expression of their parental genes or other genes involved in processes such as tumor suppression or oncogenesis[1]. No direct involvement of RHOXF1P2 in pathologies, nor any drug, biomarker, or safety concerns related to this pseudogene, have been reported in the scientific literature or gene databases[5]. **Note:** RHOXF1P2 is by definition *not* a conventional therapeutic target or receptor, and its function, if any, would be indirect or regulatory based on the emerging understanding of pseudogene biology[1][5].

Other names
Rhox homeobox family member 1 pseudogene 2RHOXF1P2
02

Biological functions

May participate in gene expression regulation through RNA-based mechanisms, such as acting as a microRNA decoy or generating small interfering RNAs
03

Disease associations

Other (pseudogenes in general have been implicated in cancer and other disease regulatory processes, but no specific role for RHOXF1P2 is documented)

Beyond the preview

Go deeper on Rhox homeobox family member 1 pseudogene 2 (RHOXF1P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rhox homeobox family member 1 pseudogene 2 (RHOXF1P2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call